@book{fdi:010084984,
  title = {{I}llicit medicines in the global south : public health access and pharmaceutical regulation},
  author = {{Q}uet, {M}athieu},
  editor = {{Q}uet, {M}athieu},
  language = {{ENG}},
  abstract = {{T}his book investigates pharmaceutical regulation and the public health issue of fake or illicit medicines in developing countries. {T}he book analyses the evolution of pharmaceutical capitalism, showing how the entanglement of market and health interests has come to shape global regulation. {D}rawing on extensive fieldwork in {I}ndia, {K}enya, and {E}urope, it demonstrates how large pharmaceutical companies have used the fight against fake medicines to serve their strategic interests and protect their monopolies, sometimes to the detriment of access to medicines in developing countries. {T}he book investigates how the contemporary dynamics of pharmaceutical power in global markets have gone on to shape societies locally, resulting in more security-oriented policies. {T}hese processes highlight the key consequences of contemporary 'logistical regimes' for access to health. {P}roviding important insights on how the flows of commodities, persons, and knowledge shape contemporary access to medicines in the developing countries, this book will be of considerable interest to policy makers and regulators, and to scholars and students across sociology, science and technology studies, global health, and development studies.},
  keywords = {{MEDICAMENT} ; {POLITIQUE} {ECONOMIQUE} ; {POLITIQUE} {DE} {SANTE} ; {INDUSTRIE} {PHARMACEUTIQUE} ; {MARCHE} ; {CIRCUIT} {DE} {DISTRIBUTION} ; {LEGISLATION} ; {PROPRIETE} {INTELLECTUELLE} ; {BREVET} ; {ENQUETE} ; {INDE} ; {KENYA} ; {EUROPE}},
  address = {{L}ondres ({GBR}) ; {N}ew {Y}ork},
  publisher = {{R}outledge},
  series = {{R}outledge {G}lobal {H}ealth {S}eries},
  pages = {193},
  year = {2021},
  DOI = {10.4324/9781003194767},
  ISBN = {978-1-03-204815-4},
  URL = {https://www.documentation.ird.fr/hor/fdi:010084984},
}